Haba Laboratories

Haba Laboratories Liabilities

The The Liabilities of Haba Laboratories (4925.T) as of Oct 21, 2026 is 2.98 B JPY. In the previous year, The Liabilities was 3.42 B JPY — a change of -12.70% (lower).

Liabilities

2.98 BJPY

YoY

-12.70%

Last updated:

In 2026, Haba Laboratories's total liabilities amounted to 2.98 B JPY, a -12.70% difference from the 3.42 B JPY total liabilities in the previous year.

The Haba Laboratories Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2019
4.54 B JPY
Jan 1, 2020
5.19 B JPY
Jan 1, 2021
5.48 B JPY
Jan 1, 2022
4.12 B JPY
Jan 1, 2023
3.96 B JPY
Jan 1, 2024
3.92 B JPY
Jan 1, 2025
3.42 B JPY
Jan 1, 2026
2.98 B JPY
The Haba Laboratories Liabilities history
YEARLiabilitiesYoY
2.98 BJPY-12.70%
3.42 BJPY-12.92%
3.92 BJPY-0.86%
3.96 BJPY-4.00%
4.12 BJPY-24.75%
5.48 BJPY+5.62%
5.19 BJPY+14.20%
4.54 BJPY-13.59%
5.26 BJPY+4.95%
5.01 BJPY-7.59%
5.42 BJPY-19.05%
6.70 BJPY-10.22%
7.46 BJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Haba Laboratories Stock analysis

What does Haba Laboratories do? HABA Laboratories, Inc. generates revenue through the development, manufacture, and sale of natural cosmetics, quasi-drugs, and nutritional supplements. The company distributes its products via wholesale to department stores and through mail order services to general customers, while also selling directly at its own retail stores. Its main business focuses on women's and men's cosmetics, targeting consumers seeking natural beauty and health solutions through both retail and direct channels. The firm's revenue streams include wholesale distribution to retailers and wholesalers, alongside direct sales at its retail stores. Products are marketed under the HABA brand, with a focus on natural ingredients for cosmetics, quasi-drugs, and nutritional supplements. The company serves both individual consumers through mail order and business clients through wholesale partnerships. HABA Laboratories' business model relies on a dual approach of B2B and B2C sales, with department stores, retailers, and wholesalers as key wholesale partners. The company's product portfolio caters to the growing demand for natural personal care items, leveraging its retail presence and mail order services to reach a broad customer base. Haba Laboratories is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Haba Laboratories's Liabilities

Haba Laboratories's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Haba Laboratories's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Haba Laboratories's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Haba Laboratories's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Haba Laboratories’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Haba Laboratories stock

The Liabilities of Haba Laboratories is 2.98 B JPY in 2026.

The Liabilities of Haba Laboratories changed from 3.42 B JPY to 2.98 B JPY, representing a -12.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Haba Laboratories since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Haba Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Haba Laboratories

All Key Metrics — Haba Laboratories